Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

GSK initiates ENABLE 1 and ENABLE 2 phase III trials of eltrombopag

Nov. 9, 2007

Osteologix reports positive top-line results from STRONG clinical trial of NB-S101

Nov. 9, 2007

Preclinical data provide detail on the mechanism of action of trodusquemine

Nov. 9, 2007

Transition reports update on diabetes program

Nov. 9, 2007

Gene-Activated human glucocerebrosidase active and safe in Gaucher's disease

Nov. 9, 2007

Merck Serono submits MAA for sapropterin in the treatment of HPA

Nov. 8, 2007

New treatment option for cachexia disclosed in recent GSK patent

Nov. 7, 2007

Recent patents disclose novel agents for metabolic diseases

Nov. 7, 2007

Recent patents describe new treatment options for diabetes and associated disorders

Nov. 6, 2007

FibroGen reports novel HIF prolyl hydroxylase inhibitors in a recent patent

Nov. 6, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...